Novedades Ayuda Acceso institucional
← Volver a resultados
Ficha bibliográfica · Consulta y acceso
Artículo de revista

Complement Factor H and Complement Factor H-Related Protein 5 Mutations Associated with Atypical Hemolytic Uremic Syndrome in a Systemic Lupus Erythematosus Patient: Efficacy of Eculizumab

Sibel ERSAN et al · Turkish Society of Nephrology · 2019

Acceso abierto al texto completo
Lectura rápida. Revisá los datos básicos del recurso y luego accedé al contenido desde el botón principal. En esta ficha solo se muestra la información necesaria para identificar la obra, citarla y abrirla.
Autor / responsable
Sibel ERSAN et al
Editorial
Turkish Society of Nephrology
Año
2019
ISSN
2667-4440
ISSN
2667-4440
Idioma
eng
Publicación seriada

"ONE HUNDRED AND THIRTY-FIVE HOURS UNDER THE RUIN : A CASE WITH TRAUMATIC RHABDOMYOLYSIS IN GÖLCÜK EARTHQUAKE"

Esta publicación seriada contiene 1.344 contenidos relacionados.
Ver contenidos

Acceso al recurso

Entrá al contenido desde la opción principal o elegí otra fuente disponible.

Acceso principal

Acceso abierto al texto completo

Texto completo identificado como acceso abierto.
Abrir texto

Resumen

Descripción general del contenido del recurso.

Atypical hemolytic uremic syndrome (aHUS) is a disorder characterized by a propensity to thrombotic microangiopathy (TMA) due to defective regulation of the alternative complement pathway. Mutations in genes encoding complement factor H (CFH) and complement factor H-related proteins (CFHR) can be related with aHUS and identified in patients with rheumatologic diseases. Atypical HUS typically presents as acute kidney injury (AKI) associated with microangiopathic hemolytic anemia (MAHA) and thrombocytopenia. We describe a SLE patient with severe AKI due to aHUS related CFH and CFHR5 mutations. The patient was refractory to immunosuppressives and plasmapheresis but responded well to eculizumab.

Cómo citar

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

al, S. E. E. (2019). Complement Factor H and Complement Factor H-Related Protein 5 Mutations Associated with Atypical Hemolytic Uremic Syndrome in a Systemic Lupus Erythematosus Patient: Efficacy of Eculizumab. https://turkjnephrol.org/index.php/pub/article/view/1244

MLA

al, Sibel ERSAN et. "Complement Factor H and Complement Factor H-Related Protein 5 Mutations Associated with Atypical Hemolytic Uremic Syndrome in a Systemic Lupus Erythematosus Patient: Efficacy of Eculizumab." 2019. https://turkjnephrol.org/index.php/pub/article/view/1244.

Chicago

al, Sibel ERSAN et. 2019. "Complement Factor H and Complement Factor H-Related Protein 5 Mutations Associated with Atypical Hemolytic Uremic Syndrome in a Systemic Lupus Erythematosus Patient: Efficacy of Eculizumab.". https://turkjnephrol.org/index.php/pub/article/view/1244.

Harvard

al, S. E. E. 2019, Complement Factor H and Complement Factor H-Related Protein 5 Mutations Associated with Atypical Hemolytic Uremic Syndrome in a Systemic Lupus Erythematosus Patient: Efficacy of Eculizumab, Turkish Society of Nephrology, available at: https://turkjnephrol.org/index.php/pub/article/view/1244 [Accessed 30 Jun. 2026].

Compartir e imprimir

Guardá la ficha, copiá su enlace permanente o imprimila como PDF.

Exportar referencia

Si usás un gestor bibliográfico, podés exportar el registro en los formatos más comunes.

RIS BibTeX

Detalles del recurso

Información bibliográfica útil para confirmar que se trata del material correcto.

Título
Complement Factor H and Complement Factor H-Related Protein 5 Mutations Associated with Atypical Hemolytic Uremic Syndrome in a Systemic Lupus Erythematosus Patient: Efficacy of Eculizumab
Autor / colaboradores
Sibel ERSAN et al
Editorial
Turkish Society of Nephrology
Año de publicación
2019
ISSN
2667-4440
ISSN
2667-4440
Idioma
eng

Materias

Explorá otros recursos relacionados a partir de estas materias.

SLE; aHUS; Eculizumab
Copiado